Decoding the Mechanism Behind MCL-1 Inhibitors

Posted by

Oncotarget

Oncotarget published this editorial on June 21, 2023 in Volume 14, entitled, “Decoding the mechanism behind MCL-1 inhibitors: A pathway to understanding MCL-1 protein stability" by researchers from the Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. DOI - https://doi.org/10.18632/oncotarget.28440 Correspondence to - Aloke Sarkar - asarkar@mdanderson.org, and Varsha Gandhi - vgandhi@mdanderson.org Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28440 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - AMG-176, AZD5991, B-cell leukemia, MCL-1 inhibitor, MCL-1 protein About Oncotarget Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form, and then quickly released to Pubmed. On September 15, 2022, Oncotarget was accepted again for indexing by MEDLINE. Oncotarget is now indexed by Medline/PubMed and PMC/PubMed. To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ Twitter - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957